test

Barbara Fiorini Due

@Novo Holdings A S

Latest period2024 - Q3ReportedManaged Assets$2.013BTotal holdings37
Assets growth rate8.55%Assets growth rate (2-Q avg)18.26%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Novo Holdings A S's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 37 positions.

Assets under management

The assets under management (AUM) of Novo Holdings A S over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.013B in assets, with a quarterly growth rate of 8.55% and a 2-quarter average growth rate of 18.26%. The portfolio is managed by Barbara Fiorini Due, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
VRDNViridian Therapeutics Inc
Recent Activity
Increased 19.25%
2.7%
$54.259M
2.385M shares@ $22.75 avg price
AVBPArrivent Biopharma Inc
Recent Activity
Increased 0.36%
1.76%
$35.375M
1.505M shares@ $23.51 avg price
MRUSMerus N V
Recent Activity
Increased 3.71%
1.74%
$34.972M
700,000 shares@ $49.96 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Increased 13.38%
1.63%
$32.755M
963,663 shares@ $33.99 avg price
FDMT4d Molecular Therapeutics In
Recent Activity
Increased 7.15%
0.81%
$16.215M
1.5M shares@ $10.81 avg price
KYTXKyverna Therapeutics Inc
Recent Activity
Increased 5.72%
0.45%
$9.046M
1.85M shares@ $4.89 avg price